Michael J. Mitchell

Michael J. Mitchell

Department of Bioengineering, University of Pennsylvania

Affiliated withUniversity of Pennsylvania

Research Area

Biography

Michael J. Mitchell has not added Biography.
If you are Michael J. Mitchell and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Testing the <em>In Vitro</em> and <em>In Vivo</em> Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Publication title

Cited by 19

2023

Other Publications

Article
Year
Nanostructured Fibrous Membranes with Rose Spike-Like Architecture.

Nano letters| PubMed ID: 28819978

2017
2017
2018
Advances in Biomaterials for Drug Delivery.

Advanced materials (Deerfield Beach, Fla.)| PubMed ID: 29736981

2018
Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 30290244

2018
Biomaterials for vaccine-based cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 30312721

2018
2018
Delivery technologies for cancer immunotherapy.

Nature reviews. Drug discovery| PubMed ID: 30622344

2019
2019
Nanomaterial Interactions with Human Neutrophils.

ACS biomaterials science & engineering| PubMed ID: 31497639

2018
Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 31678653

2019
Chiral Supraparticles for Controllable Nanomedicine.

Advanced materials (Deerfield Beach, Fla.)| PubMed ID: 31686433

2020
2020
Cyclodextrins in drug delivery: applications in gene and combination therapy.

Drug delivery and translational research| PubMed ID: 32077052

2020
2021
2020
2020
2020
Delivery technologies for in utero gene therapy.

Advanced drug delivery reviews| PubMed ID: 33181188

2021
Engineering precision nanoparticles for drug delivery.

Nature reviews. Drug discovery| PubMed ID: 33277608

2021
2021
Nanomaterials for T-cell cancer immunotherapy.

Nature nanotechnology| PubMed ID: 33437036

2021
2021
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines.

Trends in molecular medicine| PubMed ID: 33836968

2021
2021
2021
2021
2021
2021
2022
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 34742747

2022
An ionizable lipid toolbox for RNA delivery.

Nature communications| PubMed ID: 34903741

2021
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 34953981

2022
Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery.

Journal of biomedical materials research. Part A| PubMed ID: 35076171

2022
2022
2022
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 35569584

2022
2022
Lipid nanodiscs give cancer a STING.

Nature materials| PubMed ID: 35606430

2022
2022
Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes.

International journal of nanomedicine| PubMed ID: 35795081

2022
Nanotechnology-based strategies against SARS-CoV-2 variants.

Nature nanotechnology| PubMed ID: 35982317

2022
Drug delivery technologies for fetal, neonatal, and maternal therapy.

Advanced drug delivery reviews| PubMed ID: 36030020

2022
A (Controlled) Spill of IL2 for Localized Treatment of Mesothelioma.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 36190329

2022
2022
2023
2023
2023